Affiliation: University Hospital
- Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United KingdomGeraldine Blanchard-Rohner
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
Pediatr Infect Dis J 32:768-76. 2013..We also assessed the impact of maternal antibody present at 2 months of age on the immune response to a primary course of quadrivalent meningococcal conjugate vaccine (MenACWY-CRM197) given at 2 and 4 months of age...
- Vaccination during pregnancy to protect infants against influenza: why and why not?Geraldine Blanchard-Rohner
Department of Pediatrics, University Hospitals of Geneva, Switzerland
Vaccine 29:7542-50. 2011..Therefore, educational interventions for the public and health care workers are necessary to increase protection of pregnant women and young infants from influenza related complications...
- The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of ageGeraldine Blanchard-Rohner
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
Vaccine 31:2441-8. 2013....
- Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancyGeraldine Blanchard-Rohner
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
Expert Rev Vaccines 10:673-84. 2011....
- Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in childrenGeraldine Blanchard-Rohner
University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, United Kingdom
J Immunol Methods 358:46-55. 2010..These data are examples of alternative methods to assess long-term protection after protein-polysaccharide conjugate vaccines, through direct measurement of memory B-cells in peripheral blood shortly after immunisation...
- Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccineGeraldine Blanchard-Rohner
Oxford Vaccine Group and the NIHR Oxford Biomedical Research Centre, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK
Vaccine 30:4153-9. 2012..That an inhibitory effect of baseline antibody cannot be assumed a priori is supported by observations in animal models, which show that baseline antibody can both suppress or enhance the antibody response to a specific antigen...
- Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdomMaheshi N Ramasamy
Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
Clin Vaccine Immunol 21:1164-8. 2014..This study has been registered at www.clinicaltrials.gov under registration no. NCT00901940.). ..
- Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humansGeraldine Blanchard-Rohner
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, United Kingdom
Blood 114:4998-5002. 2009....
- Acceptability of maternal immunization against influenza: the critical role of obstetriciansGeraldine Blanchard-Rohner
Department of Paediatrics, Children s Hospital of Geneva, Geneva, Switzerland
J Matern Fetal Neonatal Med 25:1800-9. 2012..In Switzerland, immunization was first recommended to all pregnant women in 2009. We assessed the acceptability of this recommendation and its determinants two seasons later...
- Sustaining immunity after immunization against encapsulated bacteriaGeraldine Blanchard-Rohner
Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, UK
Hum Vaccin 4:309-12. 2008..Understanding the generation of long-term immunity, by protein-polysaccharide conjugate vaccines, is essential to reduce infant mortality through the improvement of vaccine formulation and scheduling...